ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,357,000 | -17.1% | 63,113 | -43.1% | 0.01% | 0.0% |
| Q3 2020 | $1,636,000 | -19.4% | 110,883 | +22.1% | 0.01% | -40.0% |
| Q2 2020 | $2,029,000 | +34.6% | 90,839 | -14.8% | 0.01% | 0.0% |
| Q1 2020 | $1,507,000 | -37.9% | 106,650 | -28.6% | 0.01% | +25.0% |
| Q4 2019 | $2,426,000 | +833.1% | 149,283 | +4096.9% | 0.01% | +700.0% |
| Q1 2019 | $260,000 | -51.5% | 3,557 | -33.8% | 0.00% | -50.0% |
| Q3 2018 | $536,000 | – | 5,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |